Distillations: Science + Culture + History

Everyone knows that observation is a key part of the scientific method, but what does that mean for scientists who can’t see? Judith Summers-Gates is a successful, visually impaired chemist who uses a telescope to read street signs. If the thought of a blind scientist gives you pause, you’re not alone. But stop and ask yourself why. What assumptions do we make about how knowledge is produced? And who gets to produce it? And who gets to participate in science? In this episode we go deep into the history of how vision came to dominate scientific observation and how blind scientists challenge our assumptions. This is the first of two episodes about science and disability and was produced in collaboration with the Science and Disability oral history project at the Science History Institute. Credits Hosts: Alexis Pedrick and Elisabeth Berry Drago Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Audio Engineer: James Morrison Resource List Lemonick, Sam. “Artificial intelligence tools could benefit chemis

We’ve long been fascinated by the mysteries of reproduction. But that curiosity is piqued most intensely when something unexpected happens. The study of such “monstrous births,” as scientists once called them, propelled forward our understanding of how embryos and fetuses develop. And the key to unlocking this knowledge was found gathering dust in the basement of the Russian Academy of Sciences, in a macabre collection assembled by Czar Peter the Great. The story behind this collection reveals a little-known corner of the history of the life sciences and raises some big questions, like how do bodies we see as abnormal inform and define what we see as normal? And how does this influence how we think about disability today? Credits Hosts: Alexis Pedrick and Elisabeth Berry Drago Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Audio Engineer: James Morrison Music by Blue Dot Sessions: "When in the West," "Calisson," "Entwined Oddity," "Stately Shadows," "Louver," "Tuck and Point," "Our Only Lark." Add

Our new season starts August 4th! 

Over the past few weeks Distillations has been talking to people who have special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians. In this episode we talk with Magda Marquet, a biochemical engineer and an entrepreneur. Marquet has spent decades working on DNA vaccines, one of the many techniques being used to create a vaccine for Covid-19. She also sits on the board of Arcturus Therapeutics, which is developing a vaccine for the disease. She tells us about how a company she cofounded, AltheaDx, is taking on the mental health crisis, which has been exacerbated by the pandemic. And she discusses her hopes that the lessons learned during the pandemic might change society for the better.  Credits  |  Transcript Credits Host: Lisa Berry Drago Senior Producer: Mariel Carr  Producer: Rigoberto Hernandez Researcher: Jessica Wade Audio Engineer: Jonathan Pfeffer Original music by Zach Young.

We talk about COVID-19 with Robert Langer, a chemical engineer and an entrepreneur, who runs the largest biomedical engineering research laboratory in the world at MIT. He has also started numerous biotech companies, including Moderna Therapeutics, a company that’s been making headlines for the COVID-19 vaccine they’re developing. Langer told us about his work with the Gates Foundation to develop a way for vaccines to self-boost in the body, his work with the sneaker company New Balance to create masks, and his thoughts about how diagnostic testing could be better. Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Researcher: Jessica Wade Audio Engineer: Jonathan Pfeffer Original music composed by Zach Young.  

Over the next several weeks Distillations will be talking to people who have special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians. In this episode we talk to Mark Stevenson, the chief operating officer of Thermo Fisher Scientific, an instrumentation company that has designed a diagnostic test for the novel coronavirus. The company is also working on a serology test, which will determine who has already had the virus. He tells us how the company developed those tests and the role they play in managing this pandemic. Credits Host: Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Researcher: Jessica Wade Audio Engineer: Jonathan Pfeffer

Our senior producer, Mariel Carr, talks with John Maraganore, the CEO of Alnylam Pharmaceuticals, a company developing an antiviral medication for COVID-19. When news broke in January about the new coronavirus, John Maraganore made the decision to pause other drugs in development and pivot to working on an antiviral medication for this new and alarmingly infectious virus. He says it was a difficult decision, but this virus had all the ingredients to become a pandemic. “And when you have a public health crisis like this, that’s what you do.”

Over the next several weeks Distillations will be talking to people who have special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians. In this episode our producer Rigberto Hernandez talks with Katrine Bosley, who has worked in the biotech industry for more than 30 years. Until recently she was the CEO of Editas Medicine, a company that focuses on a gene-editing technology known as CRISPR. She’s now on the board of the Massachusetts Eye and Ear Hospital and is advising the facility on its quest to create a COVID-19 vaccine. She tells us how CRISPR can be used to make faster diagnostic tests and how the hospital in Boston is creating a vaccine using a gene therapy method.  “One of the things that’s important for all of us competing against this virus is to have a lot of technologically different strategies to try to make a vaccine.” Credits Hosts: Elisabeth Berry Drago, Alexis Pedrick  Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Resear

We talk to William Haseltine, a scientist, entrepreneur, and author who has lived through three epidemics (polio, HIV/AIDS, and now COVID-19). He tells us how his lab in the 1980s was better prepared to deal with HIV/AIDS than we are now for COVID-19 and what he thinks lies ahead for us with this pandemic.   Over the next several weeks Distillations will be talking to people who have special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians. Credits Hosts: Elisabeth Berry Drago, Alexis Pedrick  Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Researcher: Jessica Wade Audio Engineer: Jonathan Pfeffer​​​​​​​

Over the next several weeks Distillations will be talking to people who have special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians. In this episode we speak with Susan Weiss, a microbiology professor at the University of Pennsylvania and the director for the Penn Center for Research on Coronavirus and Emerging Pathogens. She’ll talk about her 40-years of experience researching coronaviruses, how her field reacted to the 2002 SARS and 2012 MERS outbreaks, and the importance of studying diseases that transfer from animals to humans.  Credits Hosts: Elisabeth Berry Drago Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Researcher: Jessica Wade Additional production: Dan Drago

Over the next several weeks Distillations will be talking to people who have special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians.  In this episode we speak with Sue Desmond-Hellmann, an oncologist who worked with HIV patients in San Francisco in the 1980s during the HIV/AIDS epidemic. She was also the CEO of the Bill and Melinda Gates Foundation up until December 2019. Desmond-Hellmann tells us about her experiences working as a doctor during the HIV/AIDS epidemic and as a CEO of the Gates Foundation during the Ebola pandemic. She also discusses what we learned from HIV and Ebola that can help us in fighting COVID-19.  Credits Hosts: Alexis Pedrick and Elisabeth Berry Drago Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Researcher: Lisa Grissom Image: by Krista Kennell/Fortune Most Powerful Women Summit.

Over the next several weeks Distillations will be talking to people with special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians. In this episode we speak with John C. Martin, a biomedical researcher and former CEO of Gilead Sciences. Gilead is a pharmaceutical giant best known for its antiviral therapies for HIV/AIDS and hepatitis, but it’s also the company behind remdesivir, an antiviral drug that has recently made headlines as a possible treatment for COVID-19. Martin talked to senior producer Mariel Carr about remdesivir, antiviral treatments for HIV and other illnesses, and working with Anthony “Tony” Fauci. Credits Hosts: Alexis Pedrick and Elisabeth Berry Drago Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Music: "Balti," "Tuck and Point," and "Slimheart" by Blue Dot Sessions. Research Notes "Fauci: New Drug Remdesivir Cuts Down Coronavirus Recovery Time," NBC Nightly News. April 29, 2020.

The historical curator of a new exhibition at the Mütter Museum discusses the eerie parallels between the 1918-1919 flu pandemic and the coronavirus. In the fall of 1918 the (misnomered) Spanish flu ravaged much of the world. Philadelphia was hit especially hard: it had the highest death rate of any major American city. Over the course of six weeks 12,000 people in the city died. Hospitals were overcrowded and bodies piled up. When the Mütter Museum embarked on the multiyear exhibition and public art project Spit Spreads Death, the curators and researchers behind it had no idea how relevant it would become—or how quickly.

Over the past few years our producers have been saving all the raw tape from our tracking sessions (maybe to blackmail us at some point?) But because we all need some levity these days, we dug it out for your listening pleasure. We hope these outtakes (improvised songs about the history of science, complaints about squeaky chairs, and musings about various forms of a dystopian future) amuse you as much as they amused us. "Climbing the Mountain" by Podington Bear.

Stay tuned for our upcoming season, dropping in summer 2020!

Philadelphia just had the wettest decade on record, and all that precipitation has wreaked havoc on the city’s waterways. Like most old cities, Philadelphia has a combined sewer system—that is, one pipe is used to carry both sewage and stormwater. When it rains a lot, the system gets overwhelmed, forcing the water department to send raw sewage into rivers and creeks. City officials and engineers knew this was going to be a problem when they built the sewer system in the 1800s. The reason why they used a combined system anyway can be best explained by two forces: knowledge ceilings and path dependency. In this episode we’re going to explore how the city got to this point and how, in an interesting twist, it led to Philadelphia having one of the most innovative water systems in the country.    Philadelphia is home of the Distillations podcast. For this episode we are going to break down three centuries of water-pollution history in our backyard. It is a special collaboration with the Philadelphia Inquirer as pa

In 1970 Jane Hodgson became the only person in the United States ever convicted for performing an abortion in a hospital. A patient came to her St. Paul, Minnesota OB/GYN practice seeking an abortion. She had two kids, was pregnant with her third, and had rubella.  Minnesota's abortion law was one of the strictest in the country, but Jane Hodgson broke it. Then she called her local DA and turned herself in. This is a bonus episode exploring one part of the story from our last episode: Roe v. Wade v. Rubella. Special thanks to Physicians for Reproductive Health for giving us permission to use the 2000 oral history interview with Jane Hodgson.

The story of how abortion became legal in the United States isn’t as straightforward as many of us think. The common narrative is that feminist activism and the sexual liberation movement in the 1960s led to Roe v. Wade in 1973. But it turns out the path to Roe led over some unexpected and unsettling terrain, and involves a complicated story involving culture, society, disease, and our prejudices and fears about disability. In the 1960s a rubella epidemic swept the United States and panicked every pregnant woman in the country. Rubella, also called German measles, is a disease we hardly remember anymore, but it’s the “R” in the MMR vaccine. Though the virus is relatively harmless for most people, when contracted during pregnancy, it can severely harm the developing fetus. During the epidemic many pregnant women who may have never identified as abortion-rights advocates suddenly found themselves seeking abortions and dismantling barriers to access. Though not everyone agreed with these women, people listened.

Tune in to our next episode on December 17th.

Come see Distillations LIVE for our Halloween Spooktacular! The show is Wednesday, October 30th at 7pm at the Science History Institute in Old City Philadelphia.